All In Biotech

Free tool

FAERS Monitor: Magnesium Sulfate In Dextrose 5% In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020488 or its brand name (Magnesium Sulfate In Dextrose 5% In Plastic Container, Magnesium Sulfate). Reports on generic versions are filed under their own applications.

Reports

102

Serious

89

87% of reports

Hospitalization

32

Death reported

18

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective22
  • exposure during pregnancy11
  • off label use11
  • hypermagnesaemia8
  • maternal exposure during pregnancy8
  • acute kidney injury7
  • pulmonary oedema7
  • hyperglycaemia6
  • bile duct obstruction5
  • blood bilirubin increased5
  • diarrhoea5
  • pyrexia5
  • toxicity to various agents5
  • hyperkalaemia4
  • acute respiratory failure3

Reports by year received

View as table
YearReports
20132
20141
20153
20167
20174
20189
20198
20201
202116
202224
202317
20244
20251
20265

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,057 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hypermagnesaemiaSignal82560.21310.517,766
bile duct obstructionSignal5544.9231.52,192
blood bilirubin increasedSignal538.216.2146
exposure during pregnancySignal1136.520.9346
hyperglycaemiaSignal634.015.6161
pulmonary oedemaSignal732.215.8182
acute respiratory failureSignal332.210.562
hyperkalaemiaSignal423.59.065
maternal exposure during pregnancySignal818.59.5116
acute kidney injurySignal79.44.645
toxicity to various agentsSignal56.12.617
drug ineffectiveSignal223.42.438
pyrexiaSignal53.01.35
off label useSignal112.61.510
diarrhoea51.60.71

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.